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Abstract
Accelerating implant osseointegration may reduce the
rehabilitation period and inconvenience for patients
undergoing uncemented joint replacement or procedures
using graft substitute materials. We propose that this may be
achieved using a bioactive coating to promote bone
formation by stimulating the natural repair process.
A patented protein complex containing insulin-like growth
factor II (IGF-II) and vitronectin has been tested for this
application. Proliferation of SaOS-2 osteoblast-like cells on
variously coated surfaces was measured by 3H-leucine
incorporation.
IGF-II–vitronectin complex-treated surfaces exhibit dose-
dependent enhanced cell proliferation over untreated
controls. This increase is comparable to, or exceeds, the
effect of pre-treating with foetal calf serum. Pre-adsorption
of vitronectin is required for maximal IGF-II effects.
These results, with vitronectin’s ability to adsorb readily to a
variety of surfaces [1,2], suggest that vitronectin is an
attractive vehicle to deliver a growth factor to cells via a
biomaterial surface. Furthermore, the stimulation of
osteoblastic cells by this complex suggests application to
biomaterial surfaces to accelerate osseointegration.
Figure 2. SaOS-2 proliferation on polystyrene coated with
growth factor complex. Proliferation was quantified by de novo protein
synthesis, measured as incorporation of 3H-leucine into acid-precipitated
material. SaOS-2 cells were seeded in the presence of 3H-Leucine (1µCi/mL)
and incubated for 48 hours in a humidified atmosphere at 37°C and 5% CO2.
The wells were then washed (removing unattached cells and unincorporated
3H-leucine) and treated with 5% trichloroacetic acid to precipitate cellular
protein, which was subsequently solubilized in 0.1M NaOH/ 0.5% Triton X-
100. Activities of sub-samples (100µL) were measured in a Beckman
LS5000TA liquid scintillation counter. Wells coated with foetal calf serum
were included as positive controls. This experiment was performed four
times, with the results of one representative experiment shown here. Error
bars indicate ±1 standard deviation. IGF-II dose-dependence and the
significance of the vitronectin effects were assessed using two-way analysis
of variance.
Discussion
These proliferation assays, performed on tissue culture plastic,
demonstrate:
• Significant dose-dependent response to IGF-II (p < 10-12), with
or without pre-adsorbed vitronectin, and
• Significant enhancement of responses with a vitronectin pre-
coating (p < 10-9).
Collectively, the results suggest that vitronectin adsorption and
subsequent binding of insulin-like growth factor II is an effective
means of delivering a mitogenic signal to osteoblast-like cells.
Two of the four experiments also showed a possible synergy
between the proteins, with enhancement of proliferation above the
additive effects of the two proteins individually. This will require
further investigation.
Conclusions
These data and related literature suggest a useful approach to
improve the biocompatibility and bioactivity of orthopaedic implant
materials. The experiments show that controlled adsorption of
vitronectin:IGF-II complexes can stimulate enhanced osteoblastic
cell proliferation.
Investigations are continuing into the cellular responses to
vitronectin:IGF coatings on various biomaterial surfaces, including
attachment, proliferation, differentiation and matrix synthesis.
Collectively, this data will provide an assessment of the ability of
these complexes to promote accelerated bone formation at
implanted biomaterial surfaces.
How can vitronectin help to present growth factors to cells?
Do pre-adsorbed vitronectin:IGF-II complexes alter osteoblast responses to surfaces?
Figure 1. Protein coating and cell plating procedure. Vitronectin
adsorbs readily to a variety of biomaterial and tissue culture surfaces [1,2,13-
15]. Recent studies have also demonstrated its ability to sequester and bind
insulin-like growth factor II [10-12].
In the experiments reported below, vitronectin was adsorbed from Dulbecco’s
Modified Eagle Medium (DMEM) during a two hour incubation in a humidified
atmosphere at 37°C and 5% CO2. After blocking with a bovine serum albumin
solution, various IGF-II dilutions in HEPES binding buffer were delivered and
allowed to bind over a further two hour incubation. SaOS-2 cells in serum-
free aMEM were then plated at 105 cells/well. Each treatment was applied to
triplicate wells.SaOS-2 cells IGF-II Vitronectin
Introduction
The fixation of orthopaedic implants by osseointegration and the
use of synthetic “scaffolds” as bone graft substitutes both require
the colonization of peri/intra-prosthetic spaces by osteogenic
precursor cells and their differentiation into cells expressing an
osteoblastic phenotype. Because of bone’s relatively slow natural
healing rate, it is highly desirable to accelerate this process at the
implant-bone interface, to reduce rehabilitation times and allow
earlier load-bearing.
Numerous growth factors are known to stimulate bone formation to
varying degrees. Insulin-like growth factors (IGFs) – particularly
IGF-II – are the most abundant growth factors in adult bone [3,4].
These proteins promote proliferation in cells including osteoblast
precursors [5-9] and stimulate extracellular matrix (ECM)
production in mature osteoblasts [5,8]. IGFs have recently been
shown to bind to the serum/ECM glycoprotein, vitronectin [10-12],
which in turn adsorbs readily to a range of surfaces [1,2,13-15],
suggesting a mechanism to deliver appropriate growth factors to
implantation sites.
This study investigated the ability of our patented novel growth
factor complex (WO 02/24219 A1) to accelerate osteogenic activity
on various biomaterials in vitro.
The response of living tissue to an implant is dependent on the
proteins that adsorb to the material’s surface. Pre-adsorbing a
desirable protein complex with high surface affinity may thus
provide a simple and effective means of controlling the response of
the host bone and thus enhance osseointegration.
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Figure 3. Additive effects of vitronectin and IGF-II on
osteoblast-like cell proliferation. Using data from a similar
experiment to that shown in figure 2, this graph compares the predicted and
actual additive effects of the two protein coatings. Predicted enhancement
of proliferation is indicated by the sum of the individual effects of
vitronectin and each concentration of IGF-II. All figures are shown as the
percentage increase in counts above the uncoated controls.
Two of the four experiments conducted showed significant (p < 10-4)
interaction between the effects of the vitronectin pre-coating and the
secondary IGF-II coating, as assessed by 2-way ANOVA. Further experiments
will be necessary to conclusively demonstrate any synergy between the two
proteins.
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